Pune, July 25, 2024 (GLOBE NEWSWIRE) -- Dyspnea Treatment Market Growth Analysis: “According to SNS Insider Research, The Dyspnea Treatment Market Size was valued at US$ 6.16 billion in 2023, and is ...

A 40-year-old woman who was once accustomed to frequent travel suddenly found herself struggling to breathe after just a few ...

Dual bronchodilators have been shown to broadly improve symptoms and quality of life (QOL) in patients with chronic obstructive pulmonary disease (COPD). In patients with chronic obstructive pulmonary ...

Dyspnea treatment plays a crucial role in improving breathing comfort, oxygenation, and overall quality of life in patients suffering from respiratory distress caused by underlying conditions such as ...

The global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by 2033 with a CAGR of 6.9% from ...

Renowned Tamil filmmaker Bharathiraja, hospitalized due to breathlessness, is now stable and responding satisfactorily, ...

(MENAFN- GlobeNewsWire - Nasdaq) The growing number of people suffering from respiratory disorders like chronic obstructive pulmonary disease (COPD), asthma, and heart conditions, which often cause ...